The Biotech Growth Trust (LON:BIOG) Releases Quarterly Earnings Results

The Biotech Growth Trust (LON:BIOG) announced its quarterly earnings results on Wednesday. The company reported GBX (1.90) earnings per share for the quarter, Digital Look Earnings reports. The Biotech Growth Trust had a net margin of 140.73% and a negative return on equity of 8.91%. The company had revenue of GBX 43 million for the quarter.

The Biotech Growth Trust Stock Down 1.3%

Shares of BIOG opened at GBX 1,246 on Wednesday. The business’s 50-day moving average price is GBX 1,290.02 and its 200-day moving average price is GBX 1,248.86. The Biotech Growth Trust has a twelve month low of GBX 701.63 and a twelve month high of GBX 1,374. The stock has a market cap of £244.23 million, a PE ratio of -87.13 and a beta of 0.59.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).